Social functioning study for people in treatment for opioid use
Part of Mental health clinical trials.
This study looks at how people recovering from opioid use disorder get along with a close friend or family member (called a CSO). It may help improve social support during early treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have been diagnosed with opioid use disorder in the past 12 months
- You started medication for opioid use disorder within the last 12 weeks
- You are getting treatment at a clinic in South Carolina
- You can bring a close friend or family member who also agrees to join the study
- You are not pregnant, and you do not have severe legal issues (like being in prison)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether involving a family member, partner, or friend can help a person with opioid use disorder start and stick with medication treatment. The program uses a smartphone app to provide support and guidance.
This study looks at ways to help people who have just started taking buprenorphine for opioid use disorder stick with their treatment. It tests extra support outside of a clinic to help you stay on track and feel better.
This study tests extra support to help people who recently started buprenorphine treatment for opioid use disorder stay on track with their recovery, especially if they are new to treatment or recently released from jail or prison.
This Phase 1 study tests how adding psilocybin to a standard opioid treatment (buprenorphine-naloxone) affects recovery and symptoms in people with moderate-to-severe opioid use disorder. It may help researchers understand whether this combination is safe and beneficial alongside medication for opioid withdrawal and cravings.
This trial tests whether psilocybin can help people recovering from opioid use disorder while living at a residential treatment center. If you are already taking buprenorphine/naloxone (Suboxone), methadone, or have received Sublocade, this study may be an option for you.
This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.